ΠΠΈΠ½Π΅ΠΉΠ½ΠΎ β ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Ρ ΠΈΠΌΠ΅ΡΠΈΠ·ΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π³Π΅ΠΌΠΎΠ±Π»Π°ΡΡΠΎΠ·Π°ΠΌΠΈ ΠΏΠΎΡΠ»Π΅ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΈ Π°Π»Π»ΠΎΠ³Π΅Π½Π½ΡΡ Π³Π΅ΠΌΠΎΠΏΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΡ ΡΡΠ²ΠΎΠ»ΠΎΠ²ΡΡ ΠΊΠ»Π΅ΡΠΎΠΊ
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
Π£ΡΠΏΠ΅Ρ Π°Π»Π»ΠΎΠ³Π΅Π½Π½ΠΎΠΉ Π’ΠΠ‘Π, ΡΠ΅ΠΌ Π½Π΅ ΠΌΠ΅Π½Π΅Π΅, ΠΎΠ³ΡΠ°Π½ΠΈΡΠΈΠ²Π°ΡΡ ΠΌΠ½ΠΎΠ³ΠΎΡΠΈΡΠ»Π΅Π½Π½ΡΠ΅ ΠΏΠΎΡΡΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΎΠ½Π½ΡΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ, Π² ΡΠΎΠΌ ΡΠΈΡΠ»Π΅ ΡΠ΅ ΠΈΠ· Π½ΠΈΡ , ΠΊΠΎΡΠΎΡΡΠ΅ Π²ΠΎΠ·Π½ΠΈΠΊΠ°ΡΡ Π½Π° ΡΠΎΠ½Π΅ ΡΠ»ΠΎΠΆΠ½ΡΡ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΠΉ ΠΌΠ΅ΠΆΠ΄Ρ ΠΈΠΌΠΌΡΠ½ΠΎΠΊΠΎΠΌΠΏΠ΅ΡΠ΅Π½ΡΠ½ΡΠΌΠΈ ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ Π΄ΠΎΠ½ΠΎΡΠ° ΠΈ ΡΠ΅ΡΠΈΠΏΠΈΠ΅Π½ΡΠ°, Π° ΡΠ°ΠΊΠΆΠ΅ ΠΊΠ»Π΅ΡΠΊΠ°ΠΌΠΈ ΠΎΡΠ³Π°Π½ΠΎΠ²-ΠΌΠΈΡΠ΅Π½Π΅ΠΉ Ρ ΠΎΠ·ΡΠΈΠ½Π°. Π Π½ΠΈΠΌ ΠΎΡΠ½ΠΎΡΡΡΡΡ ΠΎΡΡΠΎΡΠΆΠ΅Π½ΠΈΠ΅ ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠ°, ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ ΡΠ΅Π°ΠΊΡΠΈΠΈ «ΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°Ρ ΠΏΡΠΎΡΠΈΠ² Ρ ΠΎΠ·ΡΠΈΠ½Π°» (Π Π’ΠΠ₯), Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΠ΅… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- ΠΠΎΡΠΎΠ±ΡΠ΅Π² Π.Π. Π ΡΠΊΠΎΠ²ΠΎΠ΄ΡΡΠ²ΠΎ ΠΏΠΎ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ.// ΠΠ·Π΄Π°Π½ΠΈΠ΅ 4. Π. ΠΡΡΠ΄ΠΈΠ°ΠΌΠ΅Π΄ 2007, ΡΡΡ. 181−249.
- ΠΠ΅ΠΌΠΈΠ΄ΠΎΠ²Π° Π.Π. ΠΠ²ΡΠΎΡΠ΅ΡΠ΅ΡΠ°Ρ// ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΠΈ Π½Π° ΡΠΎΠΈΡΠΊΠ°Π½ΠΈΠ΅ ΡΡΠ΅Π½ΠΎΠΉ ΡΡΠ΅ΠΏΠ΅Π½ΠΈ ΠΊΠ°Π½Π΄ΠΈΠ΄Π°ΡΠ° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ Π½Π°ΡΠΊ. ΠΠΈΠ½Π°ΠΌΠΈΠΊΠ° Π²ΠΎΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΈΡ ΠΊΡΠΎΠ²Π΅ΡΠ²ΠΎΡΠ΅Π½ΠΈΡ ΠΈ Π³Π΅ΠΌΠΎΠΏΠΎΡΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Ρ ΠΈΠΌΠ΅ΡΠΈΠ·ΠΌ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ Π³Π΅ΠΌΠΎΠ±Π»Π°ΡΡΠΎΠ·Π°ΠΌΠΈ ΠΏΠΎΡΠ»Π΅ ΡΠ½Π°ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΈ Π°Π»Π»ΠΎΠ³Π΅Π½Π½ΠΎΠ³ΠΎ ΠΊΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π°. ΠΠΎΡΠΊΠ²Π° 1997.
- ΠΠ΅Π½Π΄Π΅Π»Π΅Π΅Π²Π° Π.Π., Π‘Π°Π²ΡΠ΅Π½ΠΊΠΎ Π. Π., ΠΡΠ±ΠΈΠΌΠΎΠ²Π° Π.Π‘.// ΠΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ Π°Π΄ΠΎΠΏΡΠΈΠ²Π½ΠΎΠΉ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠ΅ΡΠΈΠ΄ΠΈΠ²Π° Π»Π΅ΠΉΠΊΠΎΠ·Π° ΠΏΠΎΡΠ»Π΅ Π°Π»Π»ΠΎ-ΠΌΠΈΠ΅Π»ΠΎΡΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΠΈ. ΠΡΠΎΠ±Π»Π΅ΠΌΡ Π³Π΅ΠΌΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ 2002, № 3, ΡΡΡ55−56.
- ΠΠ°ΠΉΠ΄Π°Π»ΠΎΠ²Π° Π.Π., Π‘ΠΌΠΈΡΠ½ΠΎΠ²Π° Π. Π., Π‘ΡΡΠΈΠ½ Π. Π., Π‘ΠΎΠ»ΠΎΠ²ΡΠ΅Π² Π.Π―.// ΠΡΠ΅Π½ΠΊΠ° ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠ½ΡΡ Π°Π»Π»Π΅Π»Π΅ΠΉ Π»ΠΎΠΊΡΡΠ° DXS52 Π₯-Ρ ΡΠΎΠΌΠΎΡΠΎΠΌΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° Π² ΠΌΠΎΡΠΊΠΎΠ²ΡΠΊΠΎΠΉ ΠΏΠΎΠΏΡΠ»ΡΡΠΈΡ. ΠΠ΅Π½Π΅ΡΠΈΠΊΠ° 1994, Π’ΠΠΠ±, № 7, ΡΡΡ.966−968.
- ΠΠΈΡΡΡΠΈΠ½ Π.Π., Π‘ΡΡΠΈΠ½ Π. Π. Π‘ΠΎΠ»ΠΎΠ²ΡΠ΅Π² Π.Π―.// ΠΠΏΡΠ΅Π΄Π΅Π»Π΅Π½ΠΈΠ΅ ΡΠ°ΡΡΠΎΡΡ Π²ΡΡΡΠ΅ΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π°Π»Π»Π΅Π»ΡΠ½ΡΡ Π²Π°ΡΠΈΠ°Π½ΡΠΎΠ² Π³Π΅Π½Π° ΡΠ°ΠΊΡΠΎΡΠ° ΡΠΎΠ½ ΠΠΈΠ»Π»Π΅Π±ΡΠ°Π½Π΄ΡΠ° Π½Π° ΠΎΡΠ½ΠΎΠ²Π΅ ΠΏΠΎΠ»ΠΈΠΌΠΎΡΡΠΈΠ·ΠΌΠ° ΡΠΈΡΠ»Π° ΡΠ°Π½Π΄Π΅ΠΌΠ½ΡΡ ΠΏΠΎΠ²ΡΠΎΡΠΎΠ² ΠΈΠ· 40-Π³ΠΎ ΠΈΠ½ΡΡΠΎΠ½Π° ΡΡΠΎΠ³ΠΎ Π³Π΅Π½Π°. ΠΠ΅Π½Π΅ΡΠΈΠΊΠ°, 1994, Π’30, № 5, ΡΡΡ.713−717.
- ΠΡΠ±ΠΈΠΌΠΎΠ²Π° Π.Π‘., Π‘Π°Π²ΡΠ΅Π½ΠΊΠΎ Π. Π., ΠΠ΅Π½Π΄Π΅Π»Π΅Π΅Π²Π° Π. Π., ΠΈ Π΄Ρ.// Π’ΠΎΠΊΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΎΡΠ»ΠΎΠΆΠ½Π΅Π½ΠΈΡ Ρ ΡΠ΅ΡΠΈΠΏΠΈΠ΅Π½ΡΠΎΠ² ΠΊΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π°. Π’Π΅Ρ. ΠΡΡ ΠΈΠ² 1999, № 7, ΡΡΡ.27−32.
- Π‘Π°Π²ΡΠ΅Π½ΠΊΠΎ Π.Π., ΠΠ°ΡΠΎΠ²ΠΈΡΠ½ΠΈΠΊΠΎΠ²Π° Π. Π., ΠΡΠ±ΠΈΠΌΠΎΠ²Π° Π. Π‘., ΠΠ΅Π½Π΄Π΅Π»Π΅Π΅Π²Π° Π.Π.// Π’ΡΠ°Π½ΡΠΏΠ»Π°Π½ΡΠ°ΡΠΈΡ ΠΊΠΎΡΡΠ½ΠΎΠ³ΠΎ ΠΌΠΎΠ·Π³Π° ΠΏΡΠΈ ΠΎΡΡΡΡΡ ΠΌΠΈΠ΅Π»ΠΎΠΈΠ΄Π½ΡΡ Π»Π΅ΠΉΠΊΠΎΠ·Π°Ρ : Π°ΡΠ³ΡΠΌΠ΅Π½ΡΡ Π·Π° ΠΈ ΠΏΡΠΎΡΠΈΠ². Π’Π΅Ρ. Π°ΡΡ ΠΈΠ² 1993, № 7, ΡΡΡ.7−15.
- V.Savchenko, L. Mendeleeva, L. lubimova, E.Parovitchnikova.// Donor lymphocyte infusions in the treatment of AML patients relapsed after allogenic BMT. Acute Leukemia V.5 Experimental approaches and management of refractoiy diseases. 1996- pp.383−385
- Akpek G., Zahurak M.L. Piantadosi S. at al.// Development of a prognostic model for grading chronic graft versus — host disease. Blood 2001, V97, pp.1219−1226.
- Alimena G, De Guia MR, Mecucci C et al.// Cytogenetic follow-up after allogeneic bone marrow transplantation for Ph'-positive chronic myelogenous leukemia. Bone Marrow Transplantation 1990, № 5, pp.119−127.
- Alizadeh M, Bernard M, Danic B at al.// Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood 2002- V99, pp.4616−4625.
- Anderson D, Bilingham RE, Lampkin GH at al.// The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 1951- № 5, pp.379−397
- Antin JH, Childs R, Filipovich AH.// Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendation from a workshop at the 2001 tandem meetings.
- Aleya EP Kim HT, Ho V et al// Comparative outcome of nonmyeloablative and myeloablative allogeneic hematopoietic cell transplantation for patients older then 50 years of age. Blood 2005, V105, pp.1810−1814.
- Appelbaum FR.// Hatmatopoietic cell transplantation as immunotherapy. Nature 2001, N411, pp.385−389
- Appelbaum FR.// The current status of hematopoietic cell transplantation. Annu Rev Med 2003, N54, pp.491−512.
- Bader P, Niethammer D, Willasch A at al.// How and when should we monitor chimerism after allogeneic stem cell transplantation? Bone Marrow Transplant 2005, N35, pp.107−119.
- Bader P, Hoelle W, Klingebiel T at al.// Quantitative assessment of mixed hematopoietic chimerism by polymerase chain reaction after allogeneic BMT. Anticancer Res 1996, N16, pp. 1759−1763.
- Bader P, Hancock J, Kreyenberg H et al.// Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia 2002, V16, pp.1668−1672.
- Bader P, Beck J, Frey A at al.// Serial and quantitative analysis of mixed hematopoietic chimerism by PCR in patients with acute leukemias allows the prediction of relapse after allogeneic BMT. Bone Marrow Transplant 1998, N21, pp.487−495.
- Bader P, Stoll K, Huber S et al.// Characterization of lineage-specific chimerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Br J Haematol 2000- V108, pp.761−768.
- Barker JN., Wagner JE.// Umbilical cord blood transplantation: current state of the art. Curr Opin Oncol 2002, N14, pp.160−164.
- Barrett A. J., Savani B.N.// Stem cell transplantation with reduced -intensity conditioning regimens: a review of ten years experience with new transplant concerts and new therapeutic agents. Leukemia. 2006- V20, pp. 1661−1672.
- Barrios M, Jimenez-Velasco A, Roman-Gomez J et al.// Chimerism status is a useful predictor of relapse after allogeneic stem cell transplantation for acute leukemia. Haematologica 2003- N88, pp.801−810.
- Baron F, Baker JE, Storb R et al.// Kinetics of engraftment in patients with hematological malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2004- pub.ahead.
- Bentz M., Cabot G., Moos at al.// Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 1994, V83, pp. 1922−1928
- Bearman B., Appelbaum F., Buckner D. at al.// Regimen related toxicity in patients undergoing bone marrow transplantation. Clinical Oncolologi 1998, V16, № 10, pp. 1562−1568.
- Bertheas MF, Maraninchi D, Lafage M at al.// Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentation. Blood 1988, V72, pp.89−93.
- Bertheas MF, Lafage M, Blaise D at al.// Mixed chimarism after allogeneic bone marrow transplantation for leukemias. Bone Marrow Transplant 1990, N6: pp.61−63.
- Bielorai B, Trakhtenbrot L, Amariglio N at al.// Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients. Bone Marrow Transplant 2004, N34, pp.317−320.
- Blaise D, Vey N, Faucher C, Mohty M.// Current Status of reduced intencity conditioning allogeneic stem cell transplantation for acute myeloid malignancies. Blood 2007, V23, pp.1567−1575
- Blazar BR, Orr HT, Arthur DC, at al.// Restriction fragment length polymorphisms as markes of engraftment in allogeneic marrow transplantation. Blood 1985, V66. pp. 1436−1444.
- Boerwinkle E., Xiong W., Fourest E., Chan L.// Rapid typing of tandemly repeated hypervariable loci by the polymerase chain reaction: application to the apolipoprotein B 3' hypervariable region. Proc.Natl.Acad.Sci USA. 1989, N86, pp.212−216.
- Bordignon C, Carlo-Stella C, Colombo MP, De Vincentiis A, Lanata L, at al.// Cell therapy: achievements and perspectives. Haematologica 1999, N84, pp.1110−1149.
- Bornhauser M, Thiede C, Platzbecker U et al.// Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from unrelated donors in 42 patients. Clin Cancer REs 2001, N7, pp.2254−2262.
- BraunR.A., Wolf S.N., Fay J. at al. //Blood 1995, V85, № 5, pp.1391−1395.
- Brodsky RA, Smith BD.// Bone maroow transplantation for autoimmune diseases. Curr Opin Oncol 1999, N11, pp. 83−86.
- Brunei S, Casals T, Madoz P at al.// DNA polymorphism as implant markers in allogeneic bone marrow transplantation. Preliminary evaluation. Med Clin 1989, N93, pp.765−771.
- Childs R, Clave E, Contentin N at al.// Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses. Blood 1999, V94, pp.3234−3241.
- Casado LF, Steegmann JL, Pico M et al.// Stady of chimerism in long-term survivors after bone marrow transplantation for severe acquired aplastic anemia. Bone Marrow Transplant. 1996, N18, pp.405−409.
- Casarino L, Carbone C, Capucci MA at al.// Analysis of chimerism after bone marrow transplantation using specific oligonucleotide probes.// Bone Marrow Transplant 1992, N10, pp.165−170.
- CIBMTR (Center for International Blood and Marrow Transplantai Research).Volume 12 Issue 1 May 2006
- Choi S J, Lee KH, Lee JH et al.// Prognostic value of hematopoietic chimerism in patients with acute leukemia after allogeneic bone marrowtransplantation: a prospective study. Bone Marrow Transplant 2000, N26, pp.327−332.
- Collins Jr RH, Shpilberg O, Drobyski WR Porter Dl, Giralt S, et al.// Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. J Clin Oncol 1997- V15, pp.443−444.
- Cotteret S, Belloe F, Boiron JM et al.// Fluorescent in situ hybridisation on flowsorted cells as a tool for evaluating mrd after allogenic bone marrow transplantation. Cytometry 1998, 15,35 (5), pp.216−222.
- Djulbegovic B., Seidenfield J., Bonnell C., Kumar A.// Nonmyeloablative allogeneic stem cell transplantation for hematological malignancies: a systematic review. Cancer control. 2003, N10, pp.17−41.
- De Lima M, John LS, Wieder ED et al.// Double-chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units. Br J Haematol 2002, VI19, pp.773−776.
- Dermime S, Mavroudis D, Jiang YZ, Hensel N at aX. ll Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation. Bone Marrow Transplant 1997- N19, pp.989−999-
- DeWeger RA, Tilanus MG, Scheidel KC at al.// Monitoring of residual disease and guided donor leucocyte infusion after allogeneic bone marrow transplantation by chimerism analysis with short tandem repeats. Br J Haematol 2000, VI10, pp.647−653.
- Diaz MA, Kanold J, Vicent MG et al.// Using peripheral blood progenitor cells (PBPC) for transplantation in pediatric patients: a state-of-the-art review. Bone Marrow Transplant 2000, N26, pp.1291−1298.
- Diaconescu R, Flowers CR, Storer B et al.// Morbidity and mortality with nonmyeloablative compared to myeloablative conditioning before hematopoietic cell transplantation from FILA matched related donors. Blood 2004, VI04, pp. 961−968
- Djulbegovic B, Seidenfeld J, Bonnell C et al.// Nonmyeloablative allogeneic stem-cell transplantation for hematologic malignancies: a systematic review. Cancer Control 2003, V10, pp. 17−41.
- Durnam DM, Anders KR, Fisher L et al.// Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 1989, V74, pp.2220−2226-
- Elfenbein GJ, Brogaonkar DS, Bias WB, at al.// Cytogenetic evidence for reccurrence of acute myelogenous leukemia after allogeneic bone marrow transplantation in donor hematopoietic cells. Blood 1978, V52, pp.627−636.
- Feinstein LC, Sandmaier BM, Hegenbart U et al.// Nonmyeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukemia in first complete remission. Br J Haematol 2003, VI20 pp.281−288.
- Fehse B, Chukhlovin A, Kuhlcke K at al.// Real-time quantitative Y chromosome-specific PCR (QYCS-PCR) for monitoring hematopoietic chimerism after sex-mismatched allogeneic stem cell transplantation. J Hematother Stem Cell Res 2001, V10, pp.419−425.
- Fialkow PJ, Thomas ED, Bryant JI, Neiman PE.// Leukemic transformation of engrafted human marrow cells in vivo. Lancet 1972, N1, pp. 1310−1313.
- Ford C.// Cytological identification of radiation chimaeras. Nature 1956, VI77, pp.452−454
- Forman SJ, Blume KJ, Thomas ED.// Bone Marrow Transplantation. Blackwell Scientific Publications, 1994, pp.136−149, pp.204−220.
- Formankova R, Honzatkova L, Sieglova Z et a 1.// Detailed monitoring of hematopoietic chimerism in a child treated by adoptive immunotherapy for high risk of relapse after BMT for acute myeloid leukemia. Bone Marrow Transplant 2000, N25, pp.453−456.
- Formankova R, Sedlacek P, Krskova L et al.// Chimerism-directed adoptive immunotherapy in prevention and treatment of post-transplant relapse of leukemia in childhood. Haematologica 2003, V88, pp.117−118
- Frsdriksson M, Barbany G, Liljedahl U at al.// Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles. Leukemia 2004, VI8, pp.255−266.
- Gale R.P., Horowitz M.M., Rees J.K.H. at al. Chemotherapy versus transplants for AML in second remission.// Leukemia/ 1996. — Vol.10.- pp.13−19.
- Gaziev J, Lucarelli G.// Stem cell transplantation for hemoglobinopathies. Curr Opin Pediatr 2003, N15, pp.24−31.
- Gerritsen W., Jagiello C. Bourhis J. Detection of chimerism in subpopulations of cells by fluorescence in situ hybridization and immunofluorescent staining of cell surface antigens.// BMT1994, N13, pp.441−447
- Gardiner N., Lawler M., Riordan J. et al// Monitoring lineage-specific chimerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukemia. BMT 1998, N21, pp.711−719.
- Giralt S., Estey E., Abitar M. at al.// Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft versus leukemia without myeloablative therapy. Blood 1997, V89, pp.4531−4536.
- Ginsburg D, Antin JH, Smith BR, et al.// Origin of cell populations after bone marrow transplantation analysis using DNA sequence polymorphisms. Journal of Clinical Investigations 1985, V75, pp.596−603.
- Goh K, Klemperer MR.// In vivo leukemic transformation: Cytogenetic evidence of in vivo leukemic transformation of engrafted marrow cells. American Journal of Hematology 1977, N3, pp.283−290.
- Gomez JR, Garcia MJ, Serrano J et al.// Chimerism analysis in long-term survivor patients after bone marrow transplantation for severe aplastic anemia. Haematologica 1997, N82, pp.588−591.
- Gonzales M., Lopez-Perez R., Garcia-Sanz R., Perez-Simon JA., San Miguel JF.// Debate round-table: Comments concerning chimerism stadies. Leukemia. 2001, VI5, pp. 1986−1988.
- Grigg A, Bardy P, Byron et al.// Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA -identical stem cells for relapsed leukaemia and lymphoma. Bone Marrow Transplant 1999-N23, pp. 107−108.
- Guimond M, Busque L, Baron C et al.// Relapse after bone marrow transplantation: evidenct immunological mechanisms between adult and pediatric populations. Br J Haematol 2000, V109, pp.130−137.
- Gupta V, Lazarus HM, Keating A.// Myeloablative conditioning regimens for AML grafts: 30 years later. Bone Marrow Transplant 2003, N32, pp.969−978.
- Hendriks EC, de Man AJ, van Berkel YC et al.// Flow cytometric method for the routine follow-up of red cell populations after bone marrow transplantation. Br J Hematol 1997, V97, pp.141−145.
- Hill GR., Ferrara JL.// The primacy of gastrointestinal tract as a target organ of acute graft — versus host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000, V95, pp.2754−2759.
- Hoelle W, Beck JF, Dueckers G et al.// Clinical relevance of serial quantitative analysis of hematopoietic chimerism afterallogeneic stem cell transplantation in children for severe aplastic anemia. Bone Marrow Transplant 2004, N33, pp.219−223
- Hoelle W, Kreyenberg H, Lang P et al.// Haematopoietic chimerism and donor lymphocyte infusion after allogeneic SCT in children with non malignant diseases: is there an option to improve outcome? Klin Paediatr2004,33,pp:219−223.
- Horn G.T., Richards B, Klinger K.W.// 1989. Amplification of a highly polymorphic VNTR segment by the polymerase chain reaction. Nucleic Acid Res. N17, pp.2140
- Junghanss C, Boeckh M, Carter RA et al// Incidence and outcome of cytomegalovirus infections following nonmyeloablatve compared with myeloablative allogeneic stem cell transplantation, a matched controlled study. Blood 2002, V99, pp.1978−1985.
- Kern W, Schoch C, Haferlach T.// Monitoring of minimal residual disease in acute myeloid leukemia. Hematology 2005, V56, pp.283−309.
- Knechtli CJ, Goulden NJ, Hancock JP et al.// Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia. Br.J.Haematol 1998, VI02, pp.860−871.
- Knowlton RG, Brown VA, Braman JC, at al.// Use of highly polymorphic DNA probes for genotypic analysis following bone marrow transplantation. Blood 1986, V68, pp.378−385.
- Khan F, Agarwal A, Agarwal S.// Significance of chimerism in hematopoietic stem cell transplantation: new variations on an old theme Bone Marrow Transplant 2004, N34, pp. 1−12
- Kolb HJ, Schattenberg A, Goldman YM, Hertenstein B, Jacobsen N, at al.// Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995, V86, pp.2041−2050.
- Kristt D, Stein J, Yaniv I, Klein T.// Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility. Bone Marrow Transplantation 2007, N39, pp.255−268.
- Kobzev Y., Domracheva E., Zakharova A.// Fluorescence in situ hybridization studies of interphase nuclei for assessing response to therapy in patients with chronic myeloid leukemia. Cancer Genetics and Cytogenetics 1998, N106, pp. 128−134.
- Korver K, de Lange GG, van den Bergh R1 at al.// Lymphoid chimerism after allogeneic bone marrow transplantation. Y-chromatin staining of peripheral T and B lymphocytes and allotyping of serum immunoglobulinas. Transplantation 1987, V44, pp.643−650.
- Lamb Jr LS, Robbins NF, Abhyankar S et al.// Flow cytometric cell sorting combined with molecular chimerism analysis to detect minimal recurrent leukemia: good news and bad news. Bone Marrow Transplant 1997, N19 pp.1157−1161.
- LapointeC., Forest L., Lussier P.// Sequential analysis of early hematopoietic reconstitution following allogeneic bmt with fluorescence in situ hybridization (FISH). BMT 1996, N17, pp. 1143−1148.
- Lawler M, Mc Cann SR, Conneally E at al.// Chimerism following allogeneic bone marrow transplantation: detection of residual host cell using the polymerase chain reaaction. Br J haematol 1989, V73, pp.205−210.
- Lawler M, Humphries P, McCann S.// Evalution of mixed chimerism by in vitro amplification of dinucleotide repeat sequence using the polymerase of dinucleotide repeat sequences using the polymerase chain reaction. Blood 1991, V77, pp.2504−2514
- Lawler SD, Barker MC, Harris H, Morgenstern CR.// Cytogenetics studies on recipients of allogeneic transplantation. British Journal of Hematology 1985, V57, pp.232−233.
- Lawler M, Mc Cann SR, Gardiner N et al.// Mixed chimerism predicts graft rejection following BMT for severe aplastic anemia. Bone Marrow Transplant 1995, N15, pp64. (abstract)
- Lion T, Daxberger H, Dubovsky J at al.// Analysis of chimerism within specific leucocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia 2001, VI5, pp.307−310.
- Lo YM, Tein MS Lau TK at al.// Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hunt Genet 1998, N62, pp.768−775.
- Maas F, Schaap N, Kolen S at al.// Quantification of donor and recipient hemopoietic cell by real-time PCR of single nucleotide polymorphisms. Leukemia 2003, V17, pp.621−629.
- Mangioni S, Balduzzi A, Rivolta A at al.// Long-term persistence of hematopoietic chimerism following sex-mismatched bone marrow transplantation. Bone Marrow Transplant 1997, N20, pp.969−973.
- McCann S, Lawler M.// Mixed chimerism- detection and significance following BMT. Bone Marrow Transplant 1993, N11, pp.91−94.
- McCann SR, Lawler M, Humphries P.// Mixed chimerism. Br J Haematol 1991, V77, pp.257.
- McSweeney PA, Niederwieser D, Shizuru JA et al.// Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing highdose cytotoxic therapy with graft-versus-tumor effects. Blood 2001, V97 pp.3390−3400.
- Mohty M., Kuentz M., Michallet M. at al// Chronic graft versus — host disease after allogeneic blood stem cell transplantation: long — term results of a randomized study. Blood 2002, V100, pp. 3128−34.
- Molloy K, Goulden N, Lawler M et al.// Patterns of hematopoietic chimerism following bone marrow transplantation for children acute lymphoblastic leukemia from volunteer unrelated donors. Blood 1996, V87, pp.3027−3031.
- Mullis KB.// The unusual origin of the polymerase chain reaction. Sci Am 1990, N262, pp.56−61
- Newburger PE, Latt SA, Pesando JM, at al.// Leukemic relapse in donor cell after allogeneic bone marrow transplantation. Neu England Journal of Medicine 1981, V304, pp.712−714.
- Niethammer D, Goldmann SF, Flad HD at al.// Split chimerism in three patients suffering from severe combined immunodeficiency (SCID). Haematol Blood Transfus 1980, V25, pp.391−401
- Oberkircher AR, Strout MP, Herzig GP// Description of an efficient and highly informative method for the evaluation of hematopoietic chimerism following allogeneic one marrow transplantation. Bone Marrow Transplant 1995- N16, pp.695−702.
- O’Dwyer ME., Mauro MJ., Druker BJ.// Recent, advancements in the treatment of chronic myelogenous leukemia. Annu Rev Med 2002, N53 pp.369−381.
- Offit K, Burns JP, Cunningham I at al// Cytogenetic analysis of chimerism and leukemia relapse in chronic myelogenous leukemia patients after Tcell-depleted bone marrow transplantation. Blood 1990, N75, pp. 1346−1355.
- Ortega M, Escudero T, Caballin MR at al.// Follow-up of chimerism in children with hematological diseases after allogeneic hematopoietic progenitor cell transplants. Bone Marrow Transplant 1999, N24, pp.81−87.
- Perez-Simon JA, Caballero D, Diez-Campelo M et al.// Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Leukemia 2002, V16, pp.1423−1431.
- Petit T, Raynal B, Socie G et al.// Highly sensitive polymerase chain reaction methods show the frequent survival of recipient multipotent progenitors after non-T cell-depleted bone marrow transplantation. Blood 1994, V8 pp.3575−3583-
- Petz LD, Yam P, Wallace RB, et al.// Mixed hematopoietic chimerism following bone marrow transplantation for hematological malignances. Blood 1987, V70, pp.1331−1337.
- Petz LD.// The use of the them chimera in bone marrow transplantation. Bone Marrow Transplantation 1989, N4, pp. 139−140 (reply)
- Pugatsch T, Aker M, Shapiro M. Et al.// Kinetics of engraftment post non-myeloablative stem cell transplantation (full donor chimerism). Blood 2000, V96 (Suppll), pp.172.
- Ramirez M, Diaz MA, Garcia-Sanchez F at al.// Chimerism after allogeneic hematopoietic cell transplantation in childhood acute lymphoblastic leukemia. Bone Marrow Transplant 1996, N18, pp.1161−1165.
- Roman et al, Hematologica 2000
- Rose HJ. A// Handbook of Greek Mythology. Routledge: London and New York, 1989.
- Roux E, Helg C, Chapuis B et al.// Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction. Blood 1992, V72 pp.2775−2783.
- Roy DC, Tantravahi R, Murray C et al.// Natural histori of mixed chimerism after bone marrow transplantation with CD6-depleted allogeneic marrow: a stable equilibrium. Blood 1990, V75, pp.296−304.
- Sachidanandam R, Weissman D, Schmidt SC at al. //A map of human genome sequence variation containing 1,42 million single nucleotide polymorphisms. Nature 2001, V409, pp.928−933.
- Schmitz N, Godde-Salz E, Loffler H.// Cytogenetic studies on recipients of allogeneic bone marrow transplants after fractionated total body irradiation. British Jornal of Haematology 1985, V60, pp.239−245.
- Schattenberg A, de Witte T, Salden M at al.// Mixed hematopoietic chimerism after allogeneic transplantation with lymphocyte-depleted bone marrow is not associated with a higher incidence of relapse. Blood 1989, V73, pp.1367−1372
- Schaap N, Schattenberg A, Mensink E et al.// Long-term follow-up of persisting mixed chimerism after partially T-cell-depleted allogeneic stem cell transplantation. Leukemia 2002, V16, pp.13−21.
- Scharf SJ, Smith AG, Hansen JA at al.// Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995, V85, pp. 1954−1963
- Shimoni A., Nagler A.// Non-myeloablative stem cell tramsplantation (NST): chimerism testing as guidance for immune-therapeutic manipulations. Leukemia 2001, V15, pp.1967−1975.
- Scott B.L., Sandmayer B.M. Outcomes with myeloid malignancies. Hematology 2006, V6, pp.381−389.
- Scott BL, Sandmaier BM.// Reduced Intensity Allogeneic Bone Marrow Transplantation. Outcomes with myeloid malignancies. ASH Educational Book (Hematology 2006) pp.381−389.
- Shlomchik WD., Couzens MS., Tang CB. at al.// Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999- V285, pp.412−415.
- Seong CM, Giralt S, Kantarjian H et al.// Early detection of relapse by hypermetaphase fluorescence in situ hybridization after allogeneic bone marrowtransplantation for chronic mieloid leukemia. J Clin Oncol 2000, VI8 pp.1831−1836.
- Socie G, Lawler M, Gluckman E et al.// Studies on hemopoietic chimerism following allogeneic bone marrow transplantation in the molecular biology era. Leuk Res 1995, VI9, pp.497−504
- Sparkes R.// Cytogenetic analysis in human bone marrow transplantation. Cancer Genet Cytogenet 1981, V4, pp.345−3 52.
- Starzl E.Thomas.// Chimerism and tolerance in transplantation. PNAS 2004- October 5, V101, pp.14 607−14 614
- Storb R.// Nonmyeloablative preparative regimens: how relevant for acute myelogenous leukemia? Leukemia 2001, VI5, pp.662−663.
- Suttorp M, Schmitz N, Dreger P at al.// Monitoring of chimerism after allogeneic bone marrow transplantation with unmanipulated marrow by use of DNA polymorphisms. Leukemia 1993, V7, pp.679−687.
- Thiede C.// Diagnostic chimerism analysis after allogeneic stem cell transplantation. Am J Pharmacogenomics 2004, V4, pp. 177−187.
- ThiedeC, Bornhauser M, Ehninger G.// Strategies and clinical implications of chimerism diagnosis after allogeneic hematppoietic stem cell transplantation. Acta Haematol 2004, VI12, pp.16−23.
- Thiede C, Lutterbeck K, Oelschlangel U et al.// Detection of relapse by sequential monitoring of chimerism in circulating CD 34+ cells. Ann Hematol 2002, V81, S27-S28.
- Thiede C, Florek M, Bornhauser M at al.// Rapid quantification of mixed chimerism using multiplex amplification of short tandem repeat markers and fluorescence detection. Bone Marrow Transplant 1999, N23, pp. 1055−1060.
- Thiele J, Wiekenhauser C, Kvasnicka HM at al.// Mixed chimerism of erythro- and megakaryopoiesis following allogeneic bone marrow transplant. Acta Haematol 2003, V109, pp.176−183
- Thiele J, Wiekenhauser C, Kvasnicka HM at al.// Dynamics of lineage-restricted mixed chimerism following sex-mismatched allogeneic bone marrow transplantation. Histol Histopathol 2003, VI8, pp.557−574.
- Thomas ED, Storb B, Clift RA et al.// Bone marrow transplantation. N Engl J Med. 1975, V292, pp.832−843
- Thomas ED.// Bone marrow transplantation: a review. Semin Hematol 1999, V36, pp.95−103.
- Thomas ED, Blume KG, Forman SJ.// Hematopoietic Cell Transplantation, 2nd edn. Blackwell Science, Inc: Malden, Massachusetts, USA, 1999.
- Thomas ED, Bryant JI, Buckner CD, et al.// Leukemic transformation of engrafted human marrow cells in vivo. Lancet 1972, N1, pp.1310−1313.
- Truitt RL, Atasoylu AA.// Impact of pretransplant conditioning and donor T-cells on chimerism, graft-versus-host disease, graft-versus-leukemia reactivity, and tolerance after bone marrow transplantation. Blood 1991, V77, N11 pp.2515−2523.
- Trigg M.E.// Milestones in the development of pediatric hematopoietic stem cell transplantation 50 yers of progress. Pediatr Transplant 2002, V6, pp.465−474.
- Ugozzoli L, Yam P, Petz LD at al.// Amplification by polymerase chain reaction of hypervariable regions of the human genom for evaluation of chimerism after bone marrow transplantation. Blood 1991, V77, pp.1607−1615.
- Uharek L, Gassman W, Glass B, at al.// Influence of cell done and graft-versus-host reacctivity on rejection rates after allogeneic bone marrow transplantation. Blood 1992, V79, pp. 1612−1615
- Van Leewen JE, van Toi MJ, Bodzinga BG at al.// Detection of mixed chimaerism in flow-sorted cell subpopulations by PCR-amplified VNTR markers after allogeneic bone marrow transplantation. Br J Haematol 1991, V79 pp.218−225
- Van der Velden VH, Hochhaus A, Cazzaniga G et al.// Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia 2003, VI7, pp.1013−1034.
- Van Leewen JE, van Toi MJ, Joosten AM et al.// Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologicmalignancies of children is not correlated with relapse. Blood 1993, Y82 pp.1921−1928.
- Vincent PC, Young GAR, Singh S et al.// Ph1 negative haematological chimaerism after marrow transplantation in Ph' positive chronic granulocyte leukemia. British Jornal ofHaematology 1986, V63, pp.181−185.
- Vogel et al., J// Cancer Res Clin Oncol 2005.
- Winiarski J, Gustafsson A, Wester D et al.// Follow-up of chimerism, including T-and B-lymphocytes and granulocytes in children more then one year after allogeneic bone marrow transplantation. Pediatr Transplant 2000, V4 pp.132−139.
- Winiarski J, Mattsson J, Gustafsson A et al.// Engraftment and chimerism, particularly of T and B-cells, in children undergoing allogeneic bone marrow transplantation. Pediatr Transplant 1998, V2, pp. 150−156.
- Yam PY, Petz LD, Knowlton RG, at al.// Use of DNA restriction fragment length polymorphisms to document engraftment and mixed hematopoietic chimerism following bone marrow transplantation. Transplantation 1987, V43 pp.399−407.